Listed

AVITA Medical, Inc.

RCELNasdaqCIK 1762303HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$21.7m, Q2 FY2026
Operating income−$6.9m, Q2 FY2026
Net income−$7.7m, Q2 FY2026
AVITA Medical, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m13.6Revenue, Q3 FY2023, three months to 2023-09-30$13.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-07, accession 0000950170-24-123326.Report this figure14.2Revenue, Q4 FY2023, three months to 2023-12-31$14.2m. XBRL concept us-gaap:Revenues. 10-K filed 2025-02-13, accession 0000950170-25-020026. Derived: 12-month figure less the 9-month figure.Report this figure11.1Revenue, Q1 FY2024, three months to 2024-03-31$11.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-08, accession 0000950170-25-066994.Report this figure15.2Revenue, Q2 FY2024, three months to 2024-06-30$15.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-08, accession 0001762303-25-000014.Report this figure19.5Revenue, Q3 FY2024, three months to 2024-09-30$19.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-06, accession 0001193125-25-269597.Report this figure18.4Revenue, Q4 FY2024, three months to 2024-12-31$18.4m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-12, accession 0001193125-26-049031. Derived: 12-month figure less the 9-month figure.Report this figure18.5Revenue, Q1 FY2025, three months to 2025-03-31$18.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-14, accession 0001193125-26-224107.Report this figure18.4Revenue, Q2 FY2025, three months to 2025-06-30$18.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure17.1Revenue, Q3 FY2025, three months to 2025-09-30$17.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-06, accession 0001193125-25-269597.Report this figure17.6Revenue, Q4 FY2025, three months to 2025-12-31$17.6m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-12, accession 0001193125-26-049031. Derived: 12-month figure less the 9-month figure.Report this figure19.3Revenue, Q1 FY2026, three months to 2026-03-31$19.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-14, accession 0001193125-26-224107.Report this figure21.7Revenue, Q2 FY2026, three months to 2026-06-30$21.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure
Cost of revenue$m2.1Cost of revenue, Q3 FY2023, three months to 2023-09-30$2.1m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2024-11-07, accession 0000950170-24-123326.Report this figure1.8Cost of revenue, Q4 FY2023, three months to 2023-12-31$1.8m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2025-02-13, accession 0000950170-25-020026. Derived: 12-month figure less the 9-month figure.Report this figure1.5Cost of revenue, Q1 FY2024, three months to 2024-03-31$1.5m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-05-08, accession 0000950170-25-066994.Report this figure2.1Cost of revenue, Q2 FY2024, three months to 2024-06-30$2.1m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-08-08, accession 0001762303-25-000014.Report this figure3.2Cost of revenue, Q3 FY2024, three months to 2024-09-30$3.2m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-06, accession 0001193125-25-269597.Report this figure2.3Cost of revenue, Q4 FY2024, three months to 2024-12-31$2.3m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-12, accession 0001193125-26-049031. Derived: 12-month figure less the 9-month figure.Report this figure2.8Cost of revenue, Q1 FY2025, three months to 2025-03-31$2.8m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-14, accession 0001193125-26-224107.Report this figure3.5Cost of revenue, Q2 FY2025, three months to 2025-06-30$3.5m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure3.2Cost of revenue, Q3 FY2025, three months to 2025-09-30$3.2m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-06, accession 0001193125-25-269597.Report this figure3.3Cost of revenue, Q4 FY2025, three months to 2025-12-31$3.3m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-12, accession 0001193125-26-049031. Derived: 12-month figure less the 9-month figure.Report this figure3.5Cost of revenue, Q1 FY2026, three months to 2026-03-31$3.5m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-14, accession 0001193125-26-224107.Report this figure3.9Cost of revenue, Q2 FY2026, three months to 2026-06-30$3.9m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure
Gross profit$m11.5Gross profit, Q3 FY2023, three months to 2023-09-30$11.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-07, accession 0000950170-24-123326.Report this figure12.4Gross profit, Q4 FY2023, three months to 2023-12-31$12.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-02-13, accession 0000950170-25-020026. Derived: 12-month figure less the 9-month figure.Report this figure9.6Gross profit, Q1 FY2024, three months to 2024-03-31$9.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-08, accession 0000950170-25-066994.Report this figure13.1Gross profit, Q2 FY2024, three months to 2024-06-30$13.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-08, accession 0001762303-25-000014.Report this figure16.4Gross profit, Q3 FY2024, three months to 2024-09-30$16.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0001193125-25-269597.Report this figure16.1Gross profit, Q4 FY2024, three months to 2024-12-31$16.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-12, accession 0001193125-26-049031. Derived: 12-month figure less the 9-month figure.Report this figure15.7Gross profit, Q1 FY2025, three months to 2025-03-31$15.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-14, accession 0001193125-26-224107.Report this figure14.9Gross profit, Q2 FY2025, three months to 2025-06-30$14.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure13.9Gross profit, Q3 FY2025, three months to 2025-09-30$13.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0001193125-25-269597.Report this figure14.3Gross profit, Q4 FY2025, three months to 2025-12-31$14.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-12, accession 0001193125-26-049031. Derived: 12-month figure less the 9-month figure.Report this figure15.7Gross profit, Q1 FY2026, three months to 2026-03-31$15.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-14, accession 0001193125-26-224107.Report this figure17.8Gross profit, Q2 FY2026, three months to 2026-06-30$17.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure
Research and development$m4.4Research and development, Q3 FY2023, three months to 2023-09-30$4.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0000950170-24-123326.Report this figure6.8Research and development, Q4 FY2023, three months to 2023-12-31$6.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-02-13, accession 0000950170-25-020026. Derived: 12-month figure less the 9-month figure.Report this figure5.2Research and development, Q1 FY2024, three months to 2024-03-31$5.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0000950170-25-066994.Report this figure4.9Research and development, Q2 FY2024, three months to 2024-06-30$4.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-08, accession 0001762303-25-000014.Report this figure5.4Research and development, Q3 FY2024, three months to 2024-09-30$5.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269597.Report this figure4.9Research and development, Q4 FY2024, three months to 2024-12-31$4.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-12, accession 0001193125-26-049031. Derived: 12-month figure less the 9-month figure.Report this figure6.3Research and development, Q1 FY2025, three months to 2025-03-31$6.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001193125-26-224107.Report this figure5.1Research and development, Q2 FY2025, three months to 2025-06-30$5.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure3.7Research and development, Q3 FY2025, three months to 2025-09-30$3.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269597.Report this figure5.7Research and development, Q4 FY2025, three months to 2025-12-31$5.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-12, accession 0001193125-26-049031. Derived: 12-month figure less the 9-month figure.Report this figure5.6Research and development, Q1 FY2026, three months to 2026-03-31$5.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001193125-26-224107.Report this figure5.1Research and development, Q2 FY2026, three months to 2026-06-30$5.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure
Operating income$m(9.3)Operating income, Q3 FY2023, three months to 2023-09-30−$9.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-123326.Report this figure(12.3)Operating income, Q4 FY2023, three months to 2023-12-31−$12.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-13, accession 0000950170-25-020026. Derived: 12-month figure less the 9-month figure.Report this figure(17.2)Operating income, Q1 FY2024, three months to 2024-03-31−$17.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0000950170-25-066994.Report this figure(15.6)Operating income, Q2 FY2024, three months to 2024-06-30−$15.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-08, accession 0001762303-25-000014.Report this figure(13.8)Operating income, Q3 FY2024, three months to 2024-09-30−$13.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269597.Report this figure(10.0)Operating income, Q4 FY2024, three months to 2024-12-31−$10.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-12, accession 0001193125-26-049031. Derived: 12-month figure less the 9-month figure.Report this figure(11.8)Operating income, Q1 FY2025, three months to 2025-03-31−$11.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-224107.Report this figure(11.1)Operating income, Q2 FY2025, three months to 2025-06-30−$11.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure(9.2)Operating income, Q3 FY2025, three months to 2025-09-30−$9.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269597.Report this figure(10.4)Operating income, Q4 FY2025, three months to 2025-12-31−$10.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-12, accession 0001193125-26-049031. Derived: 12-month figure less the 9-month figure.Report this figure(8.8)Operating income, Q1 FY2026, three months to 2026-03-31−$8.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-224107.Report this figure(6.9)Operating income, Q2 FY2026, three months to 2026-06-30−$6.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure
Interest expense$m0.0Interest expense, Q3 FY2023, three months to 2023-09-30$10.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-07, accession 0000950170-24-123326.Report this figure1.1Interest expense, Q4 FY2023, three months to 2023-12-31$1.1m. XBRL concept us-gaap:InterestExpense. 10-K filed 2025-02-13, accession 0000950170-25-020026. Derived: 12-month figure less the 9-month figure.Report this figure1.4Interest expense, Q1 FY2024, three months to 2024-03-31$1.4m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-08, accession 0000950170-25-066994.Report this figure1.3Interest expense, Q2 FY2024, three months to 2024-06-30$1.3m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-08, accession 0001762303-25-000014.Report this figure1.4Interest expense, Q3 FY2024, three months to 2024-09-30$1.4m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269597.Report this figure1.3Interest expense, Q4 FY2024, three months to 2024-12-31$1.3m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-02-12, accession 0001193125-26-049031. Derived: 12-month figure less the 9-month figure.Report this figure1.2Interest expense, Q1 FY2025, three months to 2025-03-31$1.2m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-14, accession 0001193125-26-224107.Report this figure1.3Interest expense, Q2 FY2025, three months to 2025-06-30$1.3m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure1.3Interest expense, Q3 FY2025, three months to 2025-09-30$1.3m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269597.Report this figure1.3Interest expense, Q4 FY2025, three months to 2025-12-31$1.3m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-02-12, accession 0001193125-26-049031. Derived: 12-month figure less the 9-month figure.Report this figure1.4Interest expense, Q1 FY2026, three months to 2026-03-31$1.4m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-14, accession 0001193125-26-224107.Report this figure1.5Interest expense, Q2 FY2026, three months to 2026-06-30$1.5m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$11.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-07, accession 0000950170-24-123326.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$12.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-02-13, accession 0000950170-25-020026. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$30.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-08, accession 0000950170-25-066994.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$33.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-08, accession 0001762303-25-000014.Report this figure(0.0)Income tax, Q3 FY2024, three months to 2024-09-30−$28.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001193125-25-269597.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$19.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-12, accession 0001193125-26-049031. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$8.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-14, accession 0001193125-26-224107.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$4.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$15.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001193125-25-269597.Report this figure(0.0)Income tax, Q4 FY2025, three months to 2025-12-31−$17.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-12, accession 0001193125-26-049031. Derived: 12-month figure less the 9-month figure.Report this figure(0.0)Income tax, Q1 FY2026, three months to 2026-03-31−$11.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-14, accession 0001193125-26-224107.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$33.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure
Net income$m(8.7)Net income, Q3 FY2023, three months to 2023-09-30−$8.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-123326.Report this figure(7.1)Net income, Q4 FY2023, three months to 2023-12-31−$7.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-13, accession 0000950170-25-020026. Derived: 12-month figure less the 9-month figure.Report this figure(18.7)Net income, Q1 FY2024, three months to 2024-03-31−$18.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-08, accession 0000950170-25-066994.Report this figure(15.4)Net income, Q2 FY2024, three months to 2024-06-30−$15.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-08, accession 0001762303-25-000014.Report this figure(16.2)Net income, Q3 FY2024, three months to 2024-09-30−$16.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269597.Report this figure(11.6)Net income, Q4 FY2024, three months to 2024-12-31−$11.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-12, accession 0001193125-26-049031. Derived: 12-month figure less the 9-month figure.Report this figure(13.9)Net income, Q1 FY2025, three months to 2025-03-31−$13.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-224107.Report this figure(9.9)Net income, Q2 FY2025, three months to 2025-06-30−$9.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure(13.2)Net income, Q3 FY2025, three months to 2025-09-30−$13.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269597.Report this figure(11.6)Net income, Q4 FY2025, three months to 2025-12-31−$11.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-12, accession 0001193125-26-049031. Derived: 12-month figure less the 9-month figure.Report this figure(10.6)Net income, Q1 FY2026, three months to 2026-03-31−$10.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-224107.Report this figure(7.7)Net income, Q2 FY2026, three months to 2026-06-30−$7.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure
Diluted EPS$ per share(0.34)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0000950170-24-123326.Report this figurenot reported(0.73)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.73 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0000950170-25-066994.Report this figure(0.60)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.60 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-08, accession 0001762303-25-000014.Report this figure(0.62)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.62 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-269597.Report this figurenot reported(0.53)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.53 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001193125-26-224107.Report this figure(0.38)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.38 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure(0.46)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-269597.Report this figurenot reported(0.35)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001193125-26-224107.Report this figure(0.25)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure
Basic EPS$ per share(0.34)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0000950170-24-123326.Report this figurenot reported(0.73)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.73 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0000950170-25-066994.Report this figure(0.60)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.60 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-08, accession 0001762303-25-000014.Report this figure(0.62)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.62 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-269597.Report this figurenot reported(0.53)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.53 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001193125-26-224107.Report this figure(0.38)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.38 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure(0.46)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.46 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-269597.Report this figurenot reported(0.35)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.35 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001193125-26-224107.Report this figure(0.25)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.25 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure

Balance sheet

Cash and equivalents$9.1m, Q2 FY2026
Long-term debt$0, FY2025
Shareholders' equity−$27.8m, Q2 FY2026
AVITA Medical, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m50.9Cash and equivalents, Q3 FY2023, at 2023-09-30$50.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-09, accession 0000950170-23-062024.Report this figure22.1Cash and equivalents, FY2023, at 2023-12-31$22.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-13, accession 0000950170-25-020026.Report this figure17.0Cash and equivalents, Q1 FY2024, at 2024-03-31$17.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-13, accession 0000950170-24-058619.Report this figure17.5Cash and equivalents, Q2 FY2024, at 2024-06-30$17.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0000950170-24-093964.Report this figure18.6Cash and equivalents, Q3 FY2024, at 2024-09-30$18.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0000950170-24-123326.Report this figure14.1Cash and equivalents, FY2024, at 2024-12-31$14.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-12, accession 0001193125-26-049031.Report this figure14.9Cash and equivalents, Q1 FY2025, at 2025-03-31$14.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0000950170-25-066994.Report this figure12.2Cash and equivalents, Q2 FY2025, at 2025-06-30$12.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-08, accession 0001762303-25-000014.Report this figure15.4Cash and equivalents, Q3 FY2025, at 2025-09-30$15.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001193125-25-269597.Report this figure10.2Cash and equivalents, FY2025, at 2025-12-31$10.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure8.3Cash and equivalents, Q1 FY2026, at 2026-03-31$8.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001193125-26-224107.Report this figure9.1Cash and equivalents, Q2 FY2026, at 2026-06-30$9.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure
Current assets$m73.9Current assets, Q3 FY2023, at 2023-09-30$73.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-062024.Report this figure104Current assets, FY2023, at 2023-12-31$104.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-13, accession 0000950170-25-020026.Report this figure86.0Current assets, Q1 FY2024, at 2024-03-31$86.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-13, accession 0000950170-24-058619.Report this figure73.0Current assets, Q2 FY2024, at 2024-06-30$73.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093964.Report this figure63.9Current assets, Q3 FY2024, at 2024-09-30$63.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123326.Report this figure57.0Current assets, FY2024, at 2024-12-31$57.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-12, accession 0001193125-26-049031.Report this figure48.0Current assets, Q1 FY2025, at 2025-03-31$48.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066994.Report this figure36.3Current assets, Q2 FY2025, at 2025-06-30$36.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-08, accession 0001762303-25-000014.Report this figure41.4Current assets, Q3 FY2025, at 2025-09-30$41.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-269597.Report this figure35.5Current assets, FY2025, at 2025-12-31$35.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure31.6Current assets, Q1 FY2026, at 2026-03-31$31.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-14, accession 0001193125-26-224107.Report this figure28.4Current assets, Q2 FY2026, at 2026-06-30$28.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure
Total assets$m81.0Total assets, Q3 FY2023, at 2023-09-30$81.0m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0000950170-23-062024.Report this figure112Total assets, FY2023, at 2023-12-31$111.6m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-13, accession 0000950170-25-020026.Report this figure97.4Total assets, Q1 FY2024, at 2024-03-31$97.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-13, accession 0000950170-24-058619.Report this figure87.8Total assets, Q2 FY2024, at 2024-06-30$87.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0000950170-24-093964.Report this figure81.1Total assets, Q3 FY2024, at 2024-09-30$81.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0000950170-24-123326.Report this figure79.7Total assets, FY2024, at 2024-12-31$79.7m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-12, accession 0001193125-26-049031.Report this figure69.6Total assets, Q1 FY2025, at 2025-03-31$69.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0000950170-25-066994.Report this figure58.1Total assets, Q2 FY2025, at 2025-06-30$58.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-08, accession 0001762303-25-000014.Report this figure63.7Total assets, Q3 FY2025, at 2025-09-30$63.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001193125-25-269597.Report this figure56.4Total assets, FY2025, at 2025-12-31$56.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure51.5Total assets, Q1 FY2026, at 2026-03-31$51.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-14, accession 0001193125-26-224107.Report this figure47.8Total assets, Q2 FY2026, at 2026-06-30$47.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure
Current liabilities$m11.8Current liabilities, Q3 FY2023, at 2023-09-30$11.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-062024.Report this figure13.2Current liabilities, FY2023, at 2023-12-31$13.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-13, accession 0000950170-25-020026.Report this figure11.9Current liabilities, Q1 FY2024, at 2024-03-31$11.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-13, accession 0000950170-24-058619.Report this figure13.8Current liabilities, Q2 FY2024, at 2024-06-30$13.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093964.Report this figure17.1Current liabilities, Q3 FY2024, at 2024-09-30$17.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123326.Report this figure20.2Current liabilities, FY2024, at 2024-12-31$20.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-12, accession 0001193125-26-049031.Report this figure23.0Current liabilities, Q1 FY2025, at 2025-03-31$23.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066994.Report this figure62.6Current liabilities, Q2 FY2025, at 2025-06-30$62.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-08, accession 0001762303-25-000014.Report this figure61.8Current liabilities, Q3 FY2025, at 2025-09-30$61.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-269597.Report this figure62.7Current liabilities, FY2025, at 2025-12-31$62.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure66.7Current liabilities, Q1 FY2026, at 2026-03-31$66.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-14, accession 0001193125-26-224107.Report this figure68.7Current liabilities, Q2 FY2026, at 2026-06-30$68.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure
Total liabilities$m17.4Total liabilities, Q3 FY2023, at 2023-09-30$17.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0000950170-23-062024.Report this figure61.9Total liabilities, FY2023, at 2023-12-31$61.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-13, accession 0000950170-25-020026.Report this figure64.0Total liabilities, Q1 FY2024, at 2024-03-31$64.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-13, accession 0000950170-24-058619.Report this figure63.5Total liabilities, Q2 FY2024, at 2024-06-30$63.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0000950170-24-093964.Report this figure68.6Total liabilities, Q3 FY2024, at 2024-09-30$68.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0000950170-24-123326.Report this figure75.0Total liabilities, FY2024, at 2024-12-31$75.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-12, accession 0001193125-26-049031.Report this figure74.1Total liabilities, Q1 FY2025, at 2025-03-31$74.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0000950170-25-066994.Report this figure71.0Total liabilities, Q2 FY2025, at 2025-06-30$71.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-08, accession 0001762303-25-000014.Report this figure70.4Total liabilities, Q3 FY2025, at 2025-09-30$70.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001193125-25-269597.Report this figure73.0Total liabilities, FY2025, at 2025-12-31$73.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure74.7Total liabilities, Q1 FY2026, at 2026-03-31$74.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-14, accession 0001193125-26-224107.Report this figure75.6Total liabilities, Q2 FY2026, at 2026-06-30$75.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure
Long-term debt$mnot reported39.8Long-term debt, FY2023, at 2023-12-31$39.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-02-13, accession 0000950170-25-020026.Report this figure41.3Long-term debt, Q1 FY2024, at 2024-03-31$41.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-13, accession 0000950170-24-058619.Report this figure41.0Long-term debt, Q2 FY2024, at 2024-06-30$41.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093964.Report this figure42.5Long-term debt, Q3 FY2024, at 2024-09-30$42.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123326.Report this figure42.2Long-term debt, FY2024, at 2024-12-31$42.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-02-12, accession 0001193125-26-049031.Report this figure41.5Long-term debt, Q1 FY2025, at 2025-03-31$41.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066994.Report this figure42.2Long-term debt, Q2 FY2025, at 2025-06-30$42.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-08, accession 0001762303-25-000014.Report this figure0.0Long-term debt, Q3 FY2025, at 2025-09-30$0. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-06, accession 0001193125-25-269597.Report this figure0.0Long-term debt, FY2025, at 2025-12-31$0. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-02-12, accession 0001193125-26-049031.Report this figurenot reportednot reported
Current portion of debt$mnot reportednot reportednot reportednot reportednot reported0.0Current portion of debt, FY2024, at 2024-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-02-12, accession 0001193125-26-049031.Report this figurenot reportednot reported42.4Current portion of debt, Q3 FY2025, at 2025-09-30$42.4m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-269597.Report this figure43.0Current portion of debt, FY2025, at 2025-12-31$43.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure46.1Current portion of debt, Q1 FY2026, at 2026-03-31$46.1m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-05-14, accession 0001193125-26-224107.Report this figure46.7Current portion of debt, Q2 FY2026, at 2026-06-30$46.7m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure
Shareholders' equity$m63.0Shareholders' equity, Q3 FY2023, at 2023-09-30$63.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0000950170-24-123326.Report this figure49.1Shareholders' equity, FY2023, at 2023-12-31$49.1m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-12, accession 0001193125-26-049031.Report this figure32.6Shareholders' equity, Q1 FY2024, at 2024-03-31$32.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-08, accession 0001762303-25-000014.Report this figure23.9Shareholders' equity, Q2 FY2024, at 2024-06-30$23.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-269597.Report this figure12.2Shareholders' equity, Q3 FY2024, at 2024-09-30$12.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-269597.Report this figure4.5Shareholders' equity, FY2024, at 2024-12-31$4.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure(4.6)Shareholders' equity, Q1 FY2025, at 2025-03-31−$4.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure(12.9)Shareholders' equity, Q2 FY2025, at 2025-06-30−$12.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure(6.7)Shareholders' equity, Q3 FY2025, at 2025-09-30−$6.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-269597.Report this figure(16.7)Shareholders' equity, FY2025, at 2025-12-31−$16.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure(23.2)Shareholders' equity, Q1 FY2026, at 2026-03-31−$23.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure(27.8)Shareholders' equity, Q2 FY2026, at 2026-06-30−$27.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure

Cash flow

Operating cash flow−$3.5m, Q2 FY2026
Capital expenditure$108.0k, Q2 FY2026
AVITA Medical, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(9.0)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$9.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0000950170-24-123326. Derived: 9-month figure less the 6-month figure.Report this figure(10.9)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$10.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-13, accession 0000950170-25-020026. Derived: 12-month figure less the 9-month figure.Report this figure(20.9)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$20.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0000950170-25-066994.Report this figure(12.8)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$12.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-08, accession 0001762303-25-000014. Derived: 6-month figure less the 3-month figure.Report this figure(7.2)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$7.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-269597. Derived: 9-month figure less the 6-month figure.Report this figure(8.0)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$8.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-338101. Derived: 12-month figure less the 9-month figure.Report this figure(10.3)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$10.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001193125-26-224107.Report this figure(10.2)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$10.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-338101. Derived: 6-month figure less the 3-month figure.Report this figure(5.2)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$5.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-269597. Derived: 9-month figure less the 6-month figure.Report this figure(5.4)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$5.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-338101. Derived: 12-month figure less the 9-month figure.Report this figure(10.1)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$10.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001193125-26-224107.Report this figure(3.5)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$3.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-338101. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.5Capital expenditure, Q3 FY2023, three months to 2023-09-30$502.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0000950170-24-123326. Derived: 9-month figure less the 6-month figure.Report this figure0.3Capital expenditure, Q4 FY2023, three months to 2023-12-31$296.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-02-13, accession 0000950170-25-020026. Derived: 12-month figure less the 9-month figure.Report this figure1.1Capital expenditure, Q1 FY2024, three months to 2024-03-31$1.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-08, accession 0000950170-25-066994.Report this figure2.7Capital expenditure, Q2 FY2024, three months to 2024-06-30$2.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-08, accession 0001762303-25-000014. Derived: 6-month figure less the 3-month figure.Report this figure3.8Capital expenditure, Q3 FY2024, three months to 2024-09-30$3.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-269597. Derived: 9-month figure less the 6-month figure.Report this figure1.6Capital expenditure, Q4 FY2024, three months to 2024-12-31$1.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-12, accession 0001193125-26-049031. Derived: 12-month figure less the 9-month figure.Report this figure0.2Capital expenditure, Q1 FY2025, three months to 2025-03-31$221.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001193125-26-224107.Report this figure0.5Capital expenditure, Q2 FY2025, three months to 2025-06-30$524.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-338101. Derived: 6-month figure less the 3-month figure.Report this figure0.9Capital expenditure, Q3 FY2025, three months to 2025-09-30$934.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-269597. Derived: 9-month figure less the 6-month figure.Report this figure(0.7)Capital expenditure, Q4 FY2025, three months to 2025-12-31−$674.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-12, accession 0001193125-26-049031. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$19.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001193125-26-224107.Report this figure0.1Capital expenditure, Q2 FY2026, three months to 2026-06-30$108.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-338101. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)30.75m, Q2 FY2026
AVITA Medical, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares25.0Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3025,006,995 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0000950170-23-062024.Report this figure25.2Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3125,202,088 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-13, accession 0000950170-24-058619.Report this figure25.2Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3025,239,723 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0000950170-24-093964.Report this figure25.4Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3025,401,754 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0000950170-24-123326.Report this figure25.6Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3125,637,783 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0000950170-25-066994.Report this figure25.8Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3025,760,278 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-08, accession 0001762303-25-000014.Report this figure26.0Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3025,983,929 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-269597.Report this figure26.3Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3126,253,565 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001193125-26-224107.Report this figure26.4Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3026,367,548 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure28.4Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3028,393,445 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-269597.Report this figure30.5Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3130,540,872 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001193125-26-224107.Report this figure30.7Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3030,749,894 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure

Shares outstanding: 30.93mShares outstanding, period not labelled, at 2026-08-0330,926,847 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-338101.Report this figure at Aug 3, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. Listed shows no prices and gives no investment advice.